Clearside Biomedical researches, develops and commercializes pharmacological therapies for the treatment of eye diseases.
Business Model:
Revenue: $26.7M
Employees: 11-50
Address: 900 North Point Parkway
City: Alpharetta
State: GA
Zip: 30005
Country: US
Clearside Biomedical researches, develops and commercializes pharmacological therapies for the treatment of eye diseases.
Contact Phone:
+16782703631
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/2/2016
Ticker Symbol:
CLSD
IPO Price:
$7/share
Amount Raised:
$60M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|